Abstract
Objective
The objective was to describe the imaging and histopathologic characteristics of metastatic myxoid liposarcomas.
Materials and methods
This retrospective study was approved by the institutional review board and complied with HIPAA guidelines. The study group comprised 12 patients with metastatic myxoid liposarcoma who underwent MRI, CT, or FDG-PET. The location and imaging characteristics of the metastatic lesions were recorded, and the histopathology of all metastatic lesions was reviewed.
Results
There were 23 histologically proven metastases in 12 patients. Based on imaging criteria, there were 41 metastases. The mean time from the diagnosis of primary tumor to the first metastasis was 4.4 years. Sixty-seven percent of patients had bone and soft tissue metastases, 33% had pulmonary metastases, 33% had liver metastases, 25% had intra-abdominal, and 16% retroperitoneal metastases. CT demonstrated well-defined lobulated masses with soft tissue attenuation in all cases, without macroscopic fat component. In cases of osseous metastases, CT showed mixed lytic and sclerotic foci, with bone destruction in advanced cases. MRI demonstrated fluid-like signal intensity with mild heterogeneous enhancement in cases of soft tissue metastases. In osseous metastases, MRI showed avid heterogeneous enhancement. FDG-PET showed no significant FDG uptake for all metastases. MRI was the most useful imaging modality for osseous and soft tissue metastases.
Conclusion
Myxoid liposarcomas are soft tissue sarcomas, with a high prevalence of extrapulmonary metastases. The bones and soft tissues were the most common site of involvement, followed by the lungs and liver. MRI was the most sensitive modality in the detection of osseous and soft tissue metastases, and is the recommended modality for the diagnosis and follow-up of bone and soft tissue involvement.
Similar content being viewed by others
References
Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995; 164(1): 129–134.
Murphey MD, Arcara LK, Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics 2005; 25(5): 1371–1395.
Christopher D, Unni K, Mertens F. Adipocytic tumors. WHO classification of tumors. Pathology and genetics: tumors of soft tissue and bone. Lyon: IARC; 2002: 19–46.
Chang HR, et al. The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer 1989; 64(7): 1514–1520.
Antonescu CR, et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res 2000; 6(7): 2788–2793.
Antonescu CR, et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diagn 2000; 2(3): 132–138.
Ishii T, et al. Unusual skeletal metastases from myxoid liposarcoma only detectable by MR imaging. Eur Radiol 2003; 13(Suppl 4): L185–L191.
Ohashi T, et al. Neck metastasis of a myxoid liposarcoma of the lower extremity. Auris Nasus Larynx 2004; 31(4): 443–446.
Schwab JH, et al. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread. Ann Surg Oncol 2007; 14(4): 1507–1514.
Sobral AP, et al. Myxoid liposarcoma of the lip: correlation of histological and cytological features and review of the literature. J Oral Maxillofac Surg 2007; 65(8): 1660–1664.
Tomita H, et al. Metastatic myxoid liposarcoma in the mesentery: what is debated? Case report and a review of the literature. Am Surg 2006; 72(1): 68–70.
Tysome JR, Sandison A, Clarke PM. Myxoid liposarcoma metastatic to the thyroid gland: a case report and literature review. J Laryngol Otol 2006; 120(6): 511–513.
Yoshida K, et al. A case of myxoid liposarcoma in the right inguinal region: a case report. Hinyokika Kiyo 2006; 52(9): 727–731.
Antonescu CR, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001; 7(12): 3977–3987.
Estourgie SH, Nielsen GP, Ott MJ. Metastatic patterns of extremity myxoid liposarcoma and their outcome. J Surg Oncol 2002; 80(2): 89–93.
Schwab JH, Healey JH. FDG-PET lacks sufficient sensitivity to detect myxoid liposarcoma spinal metastases detected by MRI. Sarcoma 2007; 2007: 36785.
Schwab JH, et al. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging. Cancer 2007; 110(8): 1815–1822.
Kattapuram SV, et al. Negative scintigraphy with positive magnetic resonance imaging in bone metastases. Skeletal Radiol 1990; 19(2): 113–116.
Van Rijswijk CS, et al. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 2004; 233(2): 493–502.
Khurana JS, et al. Skeletal metastases in liposarcoma detectable only by magnetic resonance imaging. Clin Orthop Relat Res 1989; 243: 204–207.
Blair SL, et al. Multifocal extremity sarcoma: an uncommon and controversial entity. Ann Surg Oncol 1998; 5(1): 37–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sheah, K., Ouellette, H.A., Torriani, M. et al. Metastatic myxoid liposarcomas: imaging and histopathologic findings. Skeletal Radiol 37, 251–258 (2008). https://doi.org/10.1007/s00256-007-0424-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-007-0424-1